Azelnidipine
Azelnidipine is a calcium channel blocker (CCB) used in the treatment of hypertension (high blood pressure). It belongs to the dihydropyridine class of CCBs, which are known for their ability to relax and widen blood vessels, thereby improving blood flow and reducing blood pressure.
Pharmacology
Azelnidipine works by inhibiting the influx of calcium ions through L-type calcium channels in the smooth muscle cells of the vascular system. This action leads to the relaxation of the smooth muscle cells, resulting in vasodilation and a subsequent decrease in blood pressure. Unlike some other calcium channel blockers, azelnidipine has a slow onset of action and a long duration of effect, which can be beneficial in maintaining stable blood pressure levels over time.
Clinical Use
Azelnidipine is primarily prescribed for the management of hypertension. It can be used as a monotherapy or in combination with other antihypertensive agents such as angiotensin-converting enzyme inhibitors (ACE inhibitors) or angiotensin II receptor blockers (ARBs). The typical dosage of azelnidipine is individualized based on the patient's response and tolerance to the medication.
Side Effects
Common side effects of azelnidipine include:
Less common but more serious side effects may include:
Patients are advised to report any unusual symptoms to their healthcare provider promptly.
Contraindications
Azelnidipine is contraindicated in patients with:
- Severe aortic stenosis
- Known hypersensitivity to azelnidipine or any of its components
Mechanism of Action
Azelnidipine selectively inhibits the L-type calcium channels in the vascular smooth muscle, leading to a reduction in intracellular calcium levels. This inhibition prevents the contraction of the smooth muscle cells, causing vasodilation and a reduction in peripheral vascular resistance. The long-acting nature of azelnidipine helps in maintaining a consistent antihypertensive effect with once-daily dosing.
Comparison with Other Calcium Channel Blockers
Azelnidipine is often compared with other dihydropyridine calcium channel blockers such as amlodipine and nifedipine. While all these medications share a similar mechanism of action, azelnidipine is noted for its slower onset and longer duration of action, which may result in fewer fluctuations in blood pressure and a lower incidence of reflex tachycardia.
Research and Development
Ongoing research is exploring the potential benefits of azelnidipine in other cardiovascular conditions and its long-term effects on cardiovascular morbidity and mortality. Studies are also investigating its use in combination therapies to enhance its antihypertensive efficacy and reduce side effects.
See Also
References
External Links
-
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD